Recombinant Cytomegalovirus Glycoprotein B (ab43040)
Key features and details
- Expression system: Escherichia coli
- Purity: > 95% SDS-PAGE
- Suitable for: ELISA, WB
製品の詳細
-
製品名
Recombinant Cytomegalovirus Glycoprotein B
Cytomegalovirus Glycoprotein B タンパク質・ペプチド 製品一覧 -
生理活性
Immunoreactive with sera of CMV infected individuals. -
精製度
> 95 % SDS-PAGE.
Sepharose derived purification. -
発現系
Escherichia coli -
タンパク質長
Protein fragment -
Animal free
No -
由来
Recombinant -
-
配列の追加情報
The protein contains the Cytomegalovirus (CMV) gB immunodominant regions.
-
-
製品の詳細
Recombinant Cytomegalovirus Glycoprotein B
特性
Our Abpromise guarantee covers the use of ab43040 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
アプリケーション
ELISA
Western blot
-
製品の状態
Liquid -
Concentration information loading...
前処理および保存
-
保存方法および安定性
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
pH: 7.20
Constituents: 0.395% Tris HCl, 0.0292% EDTA, 50% Glycerol
関連情報
-
別名
- CMV glycoprotein B
- Glycoprotein B
- HCMV
see all -
関連性
Human cytomegalovirus (HCMV) glycoprotein B (gB) is an abundant virion envelope protein that has been shown to be essential for the infectivity of HCMV. HCMV gB is also one of the most immunogenic virus-encoded proteins, and a significant fraction of virus neutralizing antibodies are directed at gB. -
細胞内局在
Virus envelope.
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (5)
ab43040 は 5 報の論文で使用されています。
- Gomes AC et al. The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread. Nat Commun 14:1041 (2023). PubMed: 36823200
- Davies EL et al. HCMV carriage in the elderly diminishes anti-viral functionality of the adaptive immune response resulting in virus replication at peripheral sites. Front Immunol 13:1083230 (2022). PubMed: 36591233
- Richardson SI et al. IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody. PLoS Pathog 15:e1008064 (2019). PubMed: 31841557
- Pires F et al. A rapid magnetic particle-based enzyme immunoassay for human cytomegalovirus glycoprotein B quantification. J Pharm Biomed Anal 156:372-378 (2018). PubMed: 29758495
- Crawford LB et al. Human Cytomegalovirus Induces Cellular and Humoral Virus-specific Immune Responses in Humanized BLT Mice. Sci Rep 7:937 (2017). ELISA . PubMed: 28428537